A Comprehensive Account on Recent Progress in Pharmacological Activities of Benzimidazole Derivatives

Overview

Journal Front Pharmacol

Date 2021 Nov 22

PMID 34803707

Citations 18

Authors

Shejuti Rahman Brishty

Md Jamal Hossain

Mayeen Uddin Khandaker

Mohammad Rashed Iqbal Faruque

Hamid Osman

S M Abdur Rahman

Affiliations

Soon will be listed here.

Abstract

Nowadays, nitrogenous heterocyclic molecules have attracted a great deal of interest among medicinal chemists. Among these potential heterocyclic drugs, benzimidazole scaffolds are considerably prevalent. Due to their isostructural pharmacophore of naturally occurring active biomolecules, benzimidazole derivatives have significant importance as chemotherapeutic agents in diverse clinical conditions. Researchers have synthesized plenty of benzimidazole derivatives in the last decades, amidst a large share of these compounds exerted excellent bioactivity against many ailments with outstanding bioavailability, safety, and stability profiles. In this comprehensive review, we have summarized the bioactivity of the benzimidazole derivatives reported in recent literature (2012-2021) with their available structure-activity relationship. Compounds bearing benzimidazole nucleus possess broad-spectrum pharmacological properties ranging from common antibacterial effects to the world's most virulent diseases. Several promising therapeutic candidates are undergoing human trials, and some of these are going to be approved for clinical use. However, notable challenges, such as drug resistance, costly and tedious synthetic methods, little structural information of receptors, lack of advanced software, and so on, are still viable to be overcome for further research.

Citing Articles

Bis-3-chloropiperidines: a novel motif for anthelmintic drug design.

Kirchner M, Marner M, Kramer T, Muhlemeyer F, Eichberg J, Oberpaul M RSC Adv. 2025; 15(2):824-831.

PMID: 39802477 PMC: 11718441. DOI: 10.1039/d4ra05699j.

A Convenient One-Pot Synthesis of Novel Benzimidazole-Thiazinone Derivatives and Their Antimicrobial Activity.

Samreen S, Ali A, Ahmedi S, Raghib M, Haque A, Manzoor N Antibiotics (Basel). 2025; 13(12.

PMID: 39766545 PMC: 11672583. DOI: 10.3390/antibiotics13121155.

From Deworming to Cancer Therapy: Benzimidazoles in Hematological Malignancies.

Golla U, Patel S, Shah N, Talamo S, Bhalodia R, Claxton D Cancers (Basel). 2024; 16(20).

PMID: 39456548 PMC: 11506385. DOI: 10.3390/cancers16203454.

Visible Light-Induced Radical Cascade Difluoromethylation/Cyclization of Unactivated Alkenes: Access to CFH-Substituted Polycyclic Imidazoles.

Lin S, Deng Y, Zhong H, Mao L, Ji C, Zhu X ACS Omega. 2024; 9(26):28129-28143.

PMID: 38973879 PMC: 11223139. DOI: 10.1021/acsomega.4c01177.

Identification of Innovative Folate Inhibitors Leveraging the Amino Dihydrotriazine Motif from Cycloguanil for Their Potential as Anti- Agents.

Francesconi V, Rizzo M, Pozzi C, Tagliazucchi L, Konchie Simo C, Saporito G ACS Infect Dis. 2024; 10(8):2755-2774.

PMID: 38953453 PMC: 11537224. DOI: 10.1021/acsinfecdis.4c00113.

References

Yeong K, Nor Azizi M, Berdigaliyev N, Chen W, Lee W, Shirazi A . Sirtuin inhibition and anti-cancer activities of ethyl 2-benzimidazole-5-carboxylate derivatives. Medchemcomm. 2020; 10(12):2140-2145. PMC: 7451065. DOI: 10.1039/c9md00323a. View

Akhtar S, Abbas M, Naeem K, Faheem M, Nadeem H, Mehmood A . Benzimidazole Derivative Ameliorates Opioid-Mediated Tolerance during Anticancer- Induced Neuropathic Pain in Mice. Anticancer Agents Med Chem. 2020; 21(3):365-371. DOI: 10.2174/1871520620999200818155031. View

Tonelli M, Gabriele E, Piazza F, Basilico N, Parapini S, Tasso B . Benzimidazole derivatives endowed with potent antileishmanial activity. J Enzyme Inhib Med Chem. 2017; 33(1):210-226. PMC: 7011974. DOI: 10.1080/14756366.2017.1410480. View

Morcoss M, Abdelhafez E, Ibrahem R, Abdel-Rahman H, Abdel-Aziz M, Abou El-Ella D . Design, synthesis, mechanistic studies and in silico ADME predictions of benzimidazole derivatives as novel antifungal agents. Bioorg Chem. 2020; 101:103956. DOI: 10.1016/j.bioorg.2020.103956. View

Hameed P S, Chinnapattu M, Shanbag G, Manjrekar P, Koushik K, Raichurkar A . Aminoazabenzimidazoles, a novel class of orally active antimalarial agents. J Med Chem. 2014; 57(13):5702-13. DOI: 10.1021/jm500535j. View

Xue F, Luo X, Ye C, Ye W, Wang Y . Inhibitory properties of 2-substituent-1H-benzimidazole-4-carboxamide derivatives against enteroviruses. Bioorg Med Chem. 2011; 19(8):2641-9. DOI: 10.1016/j.bmc.2011.03.007. View

Singh L, Avula S, Raj S, Srivastava A, Palnati G, Tripathi C . Coumarin-benzimidazole hybrids as a potent antimicrobial agent: synthesis and biological elevation. J Antibiot (Tokyo). 2017; 70(9):954-961. DOI: 10.1038/ja.2017.70. View

Dai D, Burgeson J, Gharaibeh D, Moore A, Larson R, Cerruti N . Discovery and optimization of potent broad-spectrum arenavirus inhibitors derived from benzimidazole. Bioorg Med Chem Lett. 2012; 23(3):744-9. DOI: 10.1016/j.bmcl.2012.11.095. View

Fjellaksel R, Boomgaren M, Sundset R, Haraldsen I, Hansen J, Riss P . Small molecule piperazinyl-benzimidazole antagonists of the gonadotropin-releasing hormone (GnRH) receptor. Medchemcomm. 2018; 8(10):1965-1969. PMC: 6072469. DOI: 10.1039/c7md00320j. View

10.

Lamotte Y, Faucher N, Sancon J, Pineau O, Sautet S, Fouchet M . Discovery of novel indazole derivatives as dual angiotensin II antagonists and partial PPARγ agonists. Bioorg Med Chem Lett. 2014; 24(4):1098-103. DOI: 10.1016/j.bmcl.2014.01.004. View

11.

Birch A, Buckett L, Turnbull A . DGAT1 inhibitors as anti-obesity and anti-diabetic agents. Curr Opin Drug Discov Devel. 2010; 13(4):489-96. View

12.

Sharma K, Shrivastava A, Mehra R, Deora G, Alam M, Zaman M . Synthesis of novel benzimidazole acrylonitriles for inhibition of Plasmodium falciparum growth by dual target inhibition. Arch Pharm (Weinheim). 2017; 351(1). DOI: 10.1002/ardp.201700251. View

13.

Suk F, Liu C, Hsu M, Chuang Y, Wang J, Liao Y . Treatment with a new benzimidazole derivative bearing a pyrrolidine side chain overcomes sorafenib resistance in hepatocellular carcinoma. Sci Rep. 2019; 9(1):17259. PMC: 6872581. DOI: 10.1038/s41598-019-53863-2. View

14.

Shaikh I, Hosamani K, Kurjogi M . Design, synthesis, and evaluation of new α-aminonitrile-based benzimidazole biomolecules as potent antimicrobial and antitubercular agents. Arch Pharm (Weinheim). 2018; 351(2). DOI: 10.1002/ardp.201700205. View

15.

Tanaka J, Iida H, Abe M, Yuda Y, Inoue S, Okabe S . Gastric antisecretory and anti-ulcer effect of ME3407, a new benzimidazole derivative, in rats. Arzneimittelforschung. 2004; 54(4):221-9. DOI: 10.1055/s-0031-1296963. View

16.

Abdelgawad M, Bakr R, Ahmad W, Al-Sanea M, Elshemy H . New pyrimidine-benzoxazole/benzimidazole hybrids: Synthesis, antioxidant, cytotoxic activity, in vitro cyclooxygenase and phospholipase A2-V inhibition. Bioorg Chem. 2019; 92:103218. DOI: 10.1016/j.bioorg.2019.103218. View

17.

De Clercq E . New Nucleoside Analogues for the Treatment of Hemorrhagic Fever Virus Infections. Chem Asian J. 2019; 14(22):3962-3968. PMC: 7159701. DOI: 10.1002/asia.201900841. View

18.

Moneer A, Mohammed K, El-Nassan H . Synthesis of Novel Substituted Thiourea and Benzimidazole Derivatives Containing a Pyrazolone Ring as Anti-Inflammatory Agents. Chem Biol Drug Des. 2015; 87(5):784-93. DOI: 10.1111/cbdd.12712. View

19.

Ferro S, Buemi M, De Luca L, Agharbaoui F, Pannecouque C, Monforte A . Searching for novel N-substituted benzimidazol-2-ones as non-nucleoside HIV-1 RT inhibitors. Bioorg Med Chem. 2017; 25(14):3861-3870. DOI: 10.1016/j.bmc.2017.05.040. View

20.

Kim M, Lee J, Jung K, Kim M, Park Y, Ahn H . Syntheses and biological evaluation of 1-heteroaryl-2-aryl-1H-benzimidazole derivatives as c-Jun N-terminal kinase inhibitors with neuroprotective effects. Bioorg Med Chem. 2013; 21(8):2271-2285. DOI: 10.1016/j.bmc.2013.02.021. View